TY - JOUR
T1 - Current management of Clostridioides (Clostridium) difficile infection in adults
T2 - A summary of recommendations from the 2017 IDSA/SHEA clinical practice guideline
AU - Ma, Jimmy
AU - Dubberke, Erik
N1 - Funding Information:
CONFLICT OF INTEREST ED received grants from Pfizer, Merck, and Re‑ biotix, consulting fees from Pfizer, Merck, Valneva, Rebiotix, Achaogen, and Synthetic Biologics, and webinar honoraria from Biofire and Abbott. JM de‑ clares no conflict of interest.
Publisher Copyright:
Copyright by Medycyna Praktyczna, Kraków 2019
PY - 2019/3
Y1 - 2019/3
N2 - Clostridioides (formerly Clostridium) difficile infection (CDI) is the most common cause of health care–associated infectious diarrhea in the developed world. The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America clinical guidelines on CDI were updated in 2017. The update reflects a decline in the incidence of CDI caused by ribotype 027 and an increased incidence of community-associated CDI, current challenges in CDI diagnosis, the importance of antibiotic stewardship and contact and isolation precautions in infection prevention and control, and many significant changes in CDI management. This review summarizes and examines these new guidelines, how they compare to other recommendations, and more recent data on CDI management.
AB - Clostridioides (formerly Clostridium) difficile infection (CDI) is the most common cause of health care–associated infectious diarrhea in the developed world. The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America clinical guidelines on CDI were updated in 2017. The update reflects a decline in the incidence of CDI caused by ribotype 027 and an increased incidence of community-associated CDI, current challenges in CDI diagnosis, the importance of antibiotic stewardship and contact and isolation precautions in infection prevention and control, and many significant changes in CDI management. This review summarizes and examines these new guidelines, how they compare to other recommendations, and more recent data on CDI management.
KW - Clostridioides difficile
KW - Clostridium difficile
KW - Guidelines
KW - Management
UR - http://www.scopus.com/inward/record.url?scp=85064009742&partnerID=8YFLogxK
U2 - 10.20452/pamw.4377
DO - 10.20452/pamw.4377
M3 - Review article
C2 - 30457126
AN - SCOPUS:85064009742
SN - 0032-3772
VL - 129
SP - 189
EP - 198
JO - Polish Archives of Internal Medicine
JF - Polish Archives of Internal Medicine
IS - 3
ER -